2015 Tina’s Wish Women’s Committee Reception featured Dr. Kara Long Roche, gynecologic oncologist from Memorial Sloan Kettering & Nancy Long, 11-year ovarian cancer survivor.
The Tina Brozman Ovarian Cancer Research Consortium brings together scientists from five leading medical institutions to advance research into the early detection and prevention of ovarian cancer.
The Honorable Tina Brozman Foundation for Ovarian Cancer Research (Tina’s Wish) was established in 2008 by Tina’s husband, Andrew, and some of Tina’s closest friends to fund research that will help save women through an effective screen for ovarian cancer, and to honor her memory as a teacher, mentor and leader.
Dr. Kara Long Roche, gynecologic oncologist from Memorial Sloan Kettering addressed the audience at the 2015 Women’s Committee Reception with her remarks entitled, “Ovarian Cancer in 2015: Advances in Screening, Prevention, and Reasons for Hope.”
Tina’s Wish has provided funding to The University of Pennsylvania’s Ovarian Cancer Center, The Yale School of Medicine/Yale Cancer Center, Memorial Sloan Kettering Cancer Center, Johns Hopkins Kimmel Cancer Center, and Dana-Farber Cancer Institute.